Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Goodman

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Pediatric Nephrology (Berlin, Germany)|June 4, 2002
Growth hormone and the skeleton in pediatric renal allograft recipientsCheryl P Sanchez, Beatriz D Kuizon, William G Goodman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 24, 2008
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study resultsSteven Fishbane, Warren B Shapiro, Dalila B Corry, et al.
American Journal of Nephrology|August 14, 2003
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patientsGlenn M Chertow, Paolo Raggi, James T McCarthy, et al.
Kidney International|April 5, 2003
Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysisIsidro B Salusky, William G Goodman, Beatriz D Kuizon, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2002
The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidismWilliam G Goodman, Gerald A Hladik, Stewart A Turner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 15, 2010
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysisPaolo Raggi, Glenn M Chertow, Pablo Urena Torres, et al.
Calcified Tissue International|October 18, 2017
Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary HyperparathyroidismLongchuan Yu, James E Tomlinson, Shawn T Alexander, et al.
Kidney International|December 11, 2002
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidismJill S Lindberg, Sharon M Moe, William G Goodman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HClSharon M Moe, John Cunningham, Jürgen Bommer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 30, 2010
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patientsJürgen Floege, Paolo Raggi, Geoffrey A Block, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Pediatric Nephrology (Berlin, Germany)|June 4, 2002
Growth hormone and the skeleton in pediatric renal allograft recipientsCheryl P Sanchez, Beatriz D Kuizon, William G Goodman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 24, 2008
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study resultsSteven Fishbane, Warren B Shapiro, Dalila B Corry, et al.
American Journal of Nephrology|August 14, 2003
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patientsGlenn M Chertow, Paolo Raggi, James T McCarthy, et al.
Kidney International|April 5, 2003
Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysisIsidro B Salusky, William G Goodman, Beatriz D Kuizon, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2002
The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidismWilliam G Goodman, Gerald A Hladik, Stewart A Turner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 15, 2010
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysisPaolo Raggi, Glenn M Chertow, Pablo Urena Torres, et al.
Calcified Tissue International|October 18, 2017
Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary HyperparathyroidismLongchuan Yu, James E Tomlinson, Shawn T Alexander, et al.
Kidney International|December 11, 2002
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidismJill S Lindberg, Sharon M Moe, William G Goodman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HClSharon M Moe, John Cunningham, Jürgen Bommer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 30, 2010
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patientsJürgen Floege, Paolo Raggi, Geoffrey A Block, et al.
Pageof 7